The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.
Open accessAbstract
Although commonly used to control a variety of inflammatory diseases, the mechanism of action of a low dose of methotrexate remains a mystery. Methotrexate accumulates intracellularly where it may interfere with purine metabolism. Therefore, we determined whether a 48-hr pretreatment with methotrexate affected adenosine release from [14C]adenine-labeled human fibroblasts and umbilical vein endothelial cells. Methotrexate significantly increased adenosine release by fibroblasts from 4 +/- 1% to 31 +/- 6% of total purine released (EC50, 1 nM) and by endothelial cells from 24 +/- 4% to 42 +/- 7%. Methotrexate-enhanced adenosine release from fibroblasts was further increased to 51 +/- 4% (EC50, 6 nM) and from endothelial cells was increased to 58 +/- 5% of total purine released by exposure to stimulated (fMet-Leu-Phe at 0.1 microM) neutrophils. The effect of methotrexate on adenosine release was not due to cytotoxicity since cells treated with maximal concentrations of methotrexate took up [14C]adenine and released 14C-labeled purine (a measure of cell injury) in a manner identical to control cells. Methotrexate treatment of fibroblasts dramatically inhibited adherence to fibroblasts by both unstimulated neutrophils (IC50, 9 nM) and stimulated neutrophils (IC50, 13 nM). Methotrexate treatment inhibited neutrophil adherence by enhancing adenosine release from fibroblasts since digestion of extracellular adenosine by added adenosine deaminase completely abrogated the effect of methotrexate on neutrophil adherence without, itself, affecting adherence. One hypothesis that explains the effect of methotrexate on adenosine release is that, by inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase, methotrexate induces the accumulation of AICAR, the nucleoside precursor of which (5-aminoimidazole-4-carboxamide ribonucleoside referred to hereafter as acadesine) has previously been shown to cause adenosine release from ischemic cardiac tissue. We found that acadesine also promotes adenosine release from and inhibits neutrophil adherence to connective tissue cells. The observation that the antiinflammatory actions of methotrexate are due to the capacity of methotrexate to induce adenosine release may form the basis for the development of an additional class of antiinflammatory drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
Turnover of adenosine in plasma of human and dog blood
Moser, G. H., Schrader, J., & Deussen, A. (1989) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1989.256.4.c799 · Cited by 529
Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.
Cronstein, B. N., Kramer, S. B., Weissmann, G., & Hirschhorn, R. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.4.1160 · Cited by 464
Self-citationAdenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells.
Cronstein, B. N., Levin, R. I., Belanoff, J., Weissmann, G., & Hirschhorn, R. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112638 · Cited by 412
Self-citationCronstein, B. N., Rosenstein, E. D., Kramer, S. B., Weissmann, G., & Hirschhorn, R. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.1366 · Cited by 345
Self-citationGUBNER, R. S., August, S., & Ginsberg, V. (1951) · PubMed · Cited by 343
Allegra, C. J., Drake, J. C., Jolivet, J., & Chabner, B. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4881 · Cited by 310
Baggott, J. E., Vaughn, W. H., & Hudson, B. B. (1986) · Biochemical Journal · doi:10.1042/bj2360193 · Cited by 205
Gruber, H. E., Hoffer, M. E., McAllister, D. R., Laikind, P. K., Lane, T. A., Schmid-Schoenbein, G. W., & Engler, R. L. (1989) · Circulation · doi:10.1161/01.cir.80.5.1400 · Cited by 201
Self-citation
Cited by
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
Haskó, G., Linden, J., Cronstein, B., & Pacher, P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2638 · Cited by 1,217
Self-citationAdenosine: an endogenous regulator of innate immunity
Haskó, G. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.11.003 · Cited by 899
Inflammatory Resolution: new opportunities for drug discovery
Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1383 · Cited by 772
Cronstein, B. N., Kimmel, S. C., Levin, R. I., Martiniuk, F., & Weissmann, G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.9991 · Cited by 725
Self-citationCronstein, B. N., Naime, D., & Ostad, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116884 · Cited by 679
Self-citationAdenosine, an endogenous anti-inflammatory agent
Cronstein, B. N. (1994) · Journal of Applied Physiology · doi:10.1152/jappl.1994.76.1.5 · Cited by 633
Self-citationLow-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis
Cronstein, B. N. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.3 · Cited by 535
Self-citationHaskó, G., Kuhel, D. G., Chen, J.-F., Schwarzschild, M. A., Deitch, E. A., Mabley, J. G., Marton, A., & Szabó, C. (2000) · The FASEB Journal · doi:10.1096/fj.99-0508com · Cited by 512
Macrophages and the maintenance of homeostasis
Mosser, D. M., Hamidzadeh, K., & Goncalves, R. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00541-3 · Cited by 505
Methotrexate an Old Drug with New Tricks
Bedoui, Y., Guillot, X., Sélambarom, J., Guiraud, P., Giry, C., Jaffar-Bandjee, M. C., Ralandison, S., & Gasque, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205023 · Cited by 471
Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., & Revillard, J. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2676 · Cited by 459
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential
Jacobson, K. A., Van Galen, P. J. M., & Williams, M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00081a001 · Cited by 456
Methotrexate mechanism in treatment of rheumatoid arthritis
Friedman, B., & Cronstein, B. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.07.004 · Cited by 439
Self-citationAnti-inflammatory mechanisms of methotrexate in rheumatoid arthritis
CUTOLO, M., SULLI, A., PIZZORNI, C., SERIOLO, B., & STRAUB, R. H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.8.729 · Cited by 433
Mechanisms of action of methotrexate
Genestier, L., Paillot, R., Quemeneur, L., Izeradjene, K., & Revillard, J.-P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00189-2 · Cited by 424
Treatment of glucocorticoid‐resistant or relapsing takayasu arteritis with methotrexate
Hoffman, G. S., Leavitt, R. Y., Kerr, G. S., Rottem, M., Sneller, M. C., & Fauci, A. S. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370420 · Cited by 409
Cronstein, B. N., Molad, Y., Reibman, J., Balakhane, E., Levin, R. I., & Weissmann, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118147 · Cited by 388
Self-citationMechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers
Brown, P. M., Pratt, A. G., & Isaacs, J. D. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.175 · Cited by 382
Koźmiński, P., Halik, P. K., Chesori, R., & Gniazdowska, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103483 · Cited by 326
Haskó, G., Kuhel, D. G., Németh, Z. H., Mabley, J. G., Stachlewitz, R. F., Virág, L., Lohinai, Z., Southan, G. J., Salzman, A. L., & Szabó, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1013 · Cited by 334
THE MECHANISM OF ACTION OF METHOTREXATE
Cronstein, B. N. (1997) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70358-6 · Cited by 312
Self-citationThe Neutrophil: Function and Regulation in Innate and Humoral Immunity
Burg, N. D., & Pillinger, M. H. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5007 · Cited by 292
Tumor-promoting functions of adenosine
Spychala, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00053-x · Cited by 284
Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review
Whittle, S. L. (2003) · Rheumatology · doi:10.1093/rheumatology/keh088 · Cited by 266
Molecular therapeutics. Methotrexate and its mechanism of action
Cronstein, B. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391203 · Cited by 265
Self-citationUrano, W., Taniguchi, A., Yamanaka, H., Tanaka, E., Nakajima, H., Matsuda, Y., Akama, H., Kitamura, Y., & Kamatani, N. (2002) · Pharmacogenetics · doi:10.1097/00008571-200204000-00002 · Cited by 264
The adhesion molecules of inflammation
Cronstein, B. N., & Weissmann, G. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360204 · Cited by 259
Self-citationMorabito, L., Montesinos, M. C., Schreibman, D. M., Balter, L., Thompson, L. F., Resta, R., Carlin, G., Huie, M. A., & Cronstein, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1554 · Cited by 259
Self-citationAdenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases
Cronstein, B. N., & Sitkovsky, M. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.178 · Cited by 258
Self-citationAdhesion Molecules in Inflammatory Diseases
Gonz??lez-Amaro, R., D??az-Gonz??lez, F., & S??nchez-Madrid, F. (1998) · Drugs · doi:10.2165/00003495-199856060-00003 · Cited by 98
Metadata
- Authors
- Cronstein, B. N., Eberle, M. A., Gruber, H. E., & Levin, R. I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1991-03-15
- Volume
- 88
- Issue
- 6
- Pages
- 2441-2445
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1990318519
- Cited by
- 332
- References
- 23
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.